Embed Size (px)
Citation preview
Update tot 30-04-2020
1. Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19
cardiovascular complications. AbdelMassiha AF, Ramzyc D, Nathanc L, Azizc S, Ashrafc M, Youssefc NH, et al.
pathogenesis. 2020;2(8):10-5.
2. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19. Abraham WT,
Fiuzat M, Psotka MA, O'Connor CM. JACC: Heart Failure. 2020;8(5):423-5.
3. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus
Disease, United States. Adams ML, Katz DL, Grandpre J. Emerg Infect Dis. 2020;26(8).
http://dx.doi.org/10.3201/eid2608.200679.
4. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus
Disease 2019 (COVID-19): A pooled analysis of published literature. Aggarwal G, Lippi G, Michael Henry B.
International journal of stroke : official journal of the International Stroke Society. 2020:1747493020921664.
http://dx.doi.org/10.1177/1747493020921664.
5. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.
Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Journal of cardiac surgery. 2020.
http://dx.doi.org/10.1111/jocs.14538.
6. COVID-19 - does exercise prescription and maximal oxygen uptake (VO2 max) have a role in
risk-stratifying patients? Ahmed I. Clinical medicine (London, England). 2020.
http://dx.doi.org/10.7861/clinmed.2020-0111.
7. [New insights into the seriousness of acute myocardial injury during COVID-19]. Alderighi C, Rasoini R,
Ambrosio G, Valente S, Gensini GF. Giornale italiano di cardiologia (2006). 2020;21(5):328-31.
http://dx.doi.org/10.1714/3343.33128.
8. Coronavirus disease 2019 (COVID-19) and cardiovascular events. Alemzadeh-Ansari M. Research in
Cardiovascular Medicine. 2020;9(1):1-2.
9. Renin-angiotensin system at the heart of COVID-19 pandemic. Alifano M, Alifano P, Forgez P, Iannelli A.
Biochimie. 2020;174:30-3.
10. [COVID-19, THE KIDNEY AND HYPERTENSION]. Angel-Korman A, Brosh T, Glick K, Leiba A. Harefuah.
2020;159(4):231-4.
11. The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat. Arshad Ali
S, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. Journal of Infection and Public Health. 2020;13(4):644-6.
12. COVID-19 outbreak: Challenges for Addiction services in India. Arya S, Gupta R. Asian Journal of
Psychiatry. 2020;51.
13. Central nervous system manifestations of COVID-19: A systematic review. Asadi-Pooya AA, Simani L.
Journal of the Neurological Sciences. 2020;413.
14. Transient complete heart block in a patient with critical COVID-19. Azarkish M, Laleh Far V, Eslami M,
Mollazadeh R. European heart journal. 2020.
15. Restructuring the inpatient advanced pharmacy practice experience to reduce the risk of contracting
coronavirus disease 2019: Lessons from Saudi Arabia. Badreldin HA, Alshaya O, Saleh KB, Alshaya AI. JACCP
Journal of the American College of Clinical Pharmacy. 2020.
16. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. Bao C, Liu
X, Zhang H, Li Y, Liu J. Journal of the American College of Radiology : JACR. 2020.
17. The hearth of mathematical and statistical modelling during the Coronavirus pandemic. Bertolaccini L,
Spaggiari L. Interactive cardiovascular and thoracic surgery. 2020.
18. Statins in coronavirus outbreak: It's time for experimental and clinical studies. Bifulco M, Gazzerro P.
Pharmacological Research. 2020;156.
19. Differential diagnosis of illness in patients under investigation for the novel coronavirus
(SARS-CoV-2), Italy, February 2020. Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, et al.
Eurosurveillance. 2020;25(8).
20. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System. Brojakowska A, Narula J,
Shimony R, Bander J. Journal of the American College of Cardiology. 2020.
http://dx.doi.org/10.1016/j.jacc.2020.04.028.
21. Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors during the
COVID-19 Pandemic. Calvillo-Arguelles O, Abdel-Qadir H, Ky B, Liu JE, Lopez-Mattei JC, Amir E, et al. JACC
CardioOncology. 2020. http://dx.doi.org/10.1016/j.jaccao.2020.04.001.
22. Neurological complications of coronavirus and COVID-19. Carod-Artal FJ. Revista de neurologia.
2020;70(9):311-22. http://dx.doi.org/10.33588/rn.7009.2020179.
23. Health system, public health, and economic implications of managing COVID-19 from a
cardiovascular perspective. Carter P, Anderson M, Mossialos E. European heart journal. 2020.
http://dx.doi.org/10.1093/eurheartj/ehaa342.
24. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel
coronavirus infection. Casey K, Iteen A, Nicolini R, Auten J. American Journal of Emergency Medicine. 2020.
25. Editorial – Differences and similarities between Severe Acute Respiratory Syndrome
(SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Ceccarelli M,
Berretta M, Rullo EV, Nunnari G, Cacopardo B. European Review for Medical and Pharmacological Sciences.
2020;24(5):2781-3.
26. Acute pulmonary embolism in a patient with COVID-19 pneumonia. Cellina M, Oliva G. Diagnostic and
Interventional Imaging. 2020.
27. COVID-19 and diabetes management: What should be considered? Ceriello A, Stoian AP, Rizzo M.
Diabetes Research and Clinical Practice. 2020;163.
28. 'COVID-19 Pandemic' Anxiety induced Tako-tsubo Cardiomyopathy. Chadha S. Qjm. 2020.
http://dx.doi.org/10.1093/qjmed/hcaa135.
29. Code Blue During the COVID-19 Pandemic. Chan PS, Berg RA, Nadkarni VM. Circulation Cardiovascular
quality and outcomes. 2020.
30. Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review. Chevance
A, Gourion D, Hoertel N, Llorca PM, Thomas P, Bocher R, et al. Encephale. 2020.
31. Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography
amidst the COVID-19 pandemic Endorsed by the American College of Cardiology. Choi AD, Abbara S, Branch KR,
Feuchtner GM, Ghoshhajra B, Nieman K, et al. Journal of Cardiovascular Computed Tomography. 2020.
32. The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic. Chung CJ, Nazif
TM, Wolbinski M, Hakemi E, Lebehn M, Brandwein R, et al. Journal of the American College of Cardiology. 2020.
33. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an
atypical acute respiratory distress syndrome working hypothesis. Ciceri F, Beretta L, Scandroglio AM, Colombo S,
Landoni G, Ruggeri A, et al. Critical care and resuscitation : journal of the Australasian Academy of Critical Care
Medicine. 2020.
34. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial
hypertension during COVID-19. Ciulla MM. European heart journal. 2020.
http://dx.doi.org/10.1093/eurheartj/ehaa331.
35. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Cui S,
Chen S, Li X, Liu S, Wang F. Journal of thrombosis and haemostasis : JTH. 2020.
36. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in
patients with diabetes during COVID-19 pandemic. Cure E, Cumhur Cure M. Diabetes and Metabolic Syndrome:
Clinical Research and Reviews. 2020;14(4):349-50.
37. Cardiac Tamponade Secondary to COVID-19. Dabbagh MF, Aurora L, D'Souza P, Weinmann AJ, Bhargava
P, Basir MB. JACC Case reports. 2020. http://dx.doi.org/10.1016/j.jaccas.2020.04.009.
38. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical
Pharmacopsychology. de Leon J, Ruan CJ, Schoretsanitis G, De Las Cuevas C. Psychotherapy and psychosomatics.
2020:1-15.
39. Covid-19, the pandemic war: Implication for neurologists. de Seze J, Lebrun-Frenay C. Revue
Neurologique. 2020;176(4):223-4.
40. Coronavirus and the hearts of doctors. D'Elia E. European journal of heart failure. 2020.
41. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to
know. Dhawan R, Gundry RL, Brett-Major DM, Mahr C, Thiele GM, Lindsey ML, et al. Journal of Molecular and Cellular
Cardiology. 2020.
42. A new threat from an old enemy: Re-emergence of coronavirus (Review). Docea AO, Tsatsakis A,
Albulescu D, Cristea O, Zlatian O, Vinceti M, et al. International Journal of Molecular Medicine. 2020;45(6):1631-43.
43. End-stage Heart Failure with COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV. Dong N,
Cai J, Zhou Y, Liu J, Li F. JACC Heart failure. 2020.
44. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Du
RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, et al. Annals of the American Thoracic Society. 2020.
45. Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic.
Duffy EY, Cainzos-Achirica M, Michos ED. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047194.
46. First COVID-19 infections in the Philippines: A case report. Edrada EM, Lopez EB, Villarama JB, Salva
Villarama EP, Dagoc BF, Smith C, et al. Tropical Medicine and Health. 2020;48(1).
47. Andrographolide As a Potential Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach.
Enmozhi SK, Raja K, Sebastine I, Joseph J. Journal of biomolecular structure & dynamics. 2020:1-10.
http://dx.doi.org/10.1080/07391102.2020.1760136.
48. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia
imported from Italy and Spain. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A,
Alarcón-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Travel Medicine and Infectious Disease.
2020.
49. Severe COVID-19 infection associated with endothelial activation. Escher R, Breakey N, Lämmle B.
Thrombosis Research. 2020;190:62.
50. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for
Prognostic Monitoring. Favaloro EJ, Lippi G. Seminars in thrombosis and hemostasis. 2020;46(3):379-82.
http://dx.doi.org/10.1055/s-0040-1709498. Epub 2020 Apr 12.
51. African American COVID-19 Mortality: A Sentinel Event. Ferdinand KC, Nasser SA. Journal of the
American College of Cardiology. 2020. http://dx.doi.org/10.1016/j.jacc.2020.04.040.
52. Cardiopulmonary resuscitation after hospital admission with covid-19. Fritz Z, Perkins GD. The BMJ.
2020;369.
53. Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment
with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
Funck-Brentano C, Salem JE, Nguyen LS, Drici MD, Roden DM. Arch Cardiovasc Dis. 2020.
http://dx.doi.org/10.1016/j.acvd.2020.04.001.
54. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine
and azithromycin. Gabriels J, Saleh M, Chang D, Epstein LM. HeartRhythm Case Reports. 2020.
55. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United
States during COVID-19 Pandemic. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al.
Journal of the American College of Cardiology. 2020.
56. Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling
approach for effective drug repurposing. Garcia-Cremades M, Solans BP, Hughes E, Ernest JP, Wallender E, Aweeka
F, et al. Clinical pharmacology and therapeutics. 2020.
57. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to
be used). Gentile S, Strollo F, Ceriello A. Diabetes Research and Clinical Practice. 2020;162.
58. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and
lessons from the past. Giannis D, Ziogas IA, Gianni P. Journal of Clinical Virology. 2020;127.
59. Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and
deaths. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Nutrients. 2020;12(4).
60. Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment
of coronavirus disease 2019. Gu M, Liu J, Shi NN, Li XD, Huang Z, Wu JK, et al. Zhongguo Zhong yao za zhi =
Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2020;45(6):1253-8.
61. Managing ACS during COVID-19 infection: Do not follow the traditional route. Guha S, Mukhopadhay
S, Karak A, Choudhury B, Kapoor A, Yadav R. Indian Heart Journal. 2020.
62. [ANMCO Position paper: Guidance for the management of suspected or confirmed COVID-19 patients
requiring urgent electrophysiological procedures]. Gulizia MM, Zecchin M, Colivicchi F, Francese GM, Murrone A,
Caldarola P, et al. Giornale italiano di cardiologia (2006). 2020;21(5):336-40. http://dx.doi.org/10.1714/3343.33130.
63. Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have
miraculous therapeutic effects? Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Journal of medical virology.
2020.
64. Pulmonary infiltration shadows associated with acute aortic dissection mimicking coronavirus
pneumonia. Hamasaki A, Kikuchi C, Hirota M, Niinami H. Journal of Cardiac Surgery. 2020.
65. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and
mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Henry BM, de Oliveira MHS, Benoit S, Plebani
M, Lippi G. Clinical chemistry and laboratory medicine. 2020.
66. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on
anticancer treatment. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, et al. European Journal of Cancer.
2020;132:11-6.
67. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19
pneumonia - A systematic review, meta-analysis, and meta-regression. Huang I, Lim MA, Pranata R. Diabetes &
metabolic syndrome. 2020;14(4):395-403. http://dx.doi.org/10.1016/j.dsx.2020.04.018.
68. COVID-19 and diabetes: Knowledge in progress. Hussain A, Bhowmik B, do Vale Moreira NC. Diabetes
Research and Clinical Practice. 2020;162.
69. Fulminant myocarditis due to COVID-19. Irabien-Ortiz Á, Carreras-Mora J, Sionis A, Pàmies J, Montiel J,
Tauron M. Revista Espanola de Cardiologia. 2020.
70. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists.
Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Stroke and Vascular Neurology. 2020.
71. Leading the Compassionate Charge. Juneman EB. Circulation Heart failure. 2020;13(4):e007085.
72. Patients with chronic illness urgently need integrated physical and psychological care during the
COVID-19 outbreak. Kang C, Yang S, Yuan J, Xu L, Zhao X, Yang J. Asian Journal of Psychiatry. 2020;51.
73. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological,
and histopathological findings. Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, et al.
Travel Medicine and Infectious Disease. 2020.
74. Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An
International Perspective. Katz JN, Sinha SS, Alviar CL, Dudzinski DM, Gage A, Brusca SB, et al. Journal of the
American College of Cardiology. 2020. http://dx.doi.org/10.1016/j.jacc.2020.04.029.
75. COVID-19 in People with Mental Illness: Challenges and Vulnerabilities. Kavoor AR. Asian Journal of
Psychiatry. 2020;51.
76. COVID-19-related myocarditis in a 21-year-old female patient. Kim IC, Kim JY, Kim HA, Han S. European
heart journal. 2020.
77. Cardiac and arrhythmic complications in patients with COVID-19. Kochi AN, Tagliari AP, Forleo GB,
Fassini GM, Tondo C. Journal of Cardiovascular Electrophysiology. 2020.
78. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]. Kreutz R, Abd
El-Hady Algharably E, Ganten D, Messerli F. Deutsche medizinische Wochenschrift (1946). 2020.
http://dx.doi.org/10.1055/a-1152-3469.
79. Hypertension, the renin-angiotensin system, and` the risk of lower respiratory tract infections and
lung injury: implications for COVID-19. Kreutz R, Algharably EAEH, Azizi M, Dobrowolski P, Guzik T, Januszewicz A,
et al. Cardiovascular research. 2020.
80. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities. Ky B,
Mann DL. JACC CardioOncology. 2020. http://dx.doi.org/10.1016/j.jaccao.2020.04.002.
81. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. Lala A,
Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, et al. medRxiv. 2020:2020.04.20.20072702.
82. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: A Position Paper of
the Italian Association of Respiratory Physiotherapists (ARIR). Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto
S, Colombo A, et al. Monaldi Archives for Chest Disease. 2020;90(1):163-8.
83. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help. Lentini G,
Cavalluzzi MM, Habtemariam S. Molecules (Basel, Switzerland). 2020;25(8).
http://dx.doi.org/10.3390/molecules25081834.
84. Cardiothoracic Education in the Time of COVID-19: How I Teach It. Lewis EE, Taylor LJ, Hermsen JL,
McCarthy DP, Fiedler AG. The Annals of thoracic surgery. 2020.
85. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity. Li
G, Li H, Lu J. Clinical research in cardiology : official journal of the German Cardiac Society. 2020.
http://dx.doi.org/10.1007/s00392-020-01653-6.
86. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With
Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. Li J, Wang X,
Chen J, Zhang H, Deng A. JAMA cardiology. 2020. http://dx.doi.org/10.1001/jamacardio.2020.1624.
87. Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China. Li R,
Tian J, Yang F, Lv L, Yu J, Sun G, et al. Journal of Clinical Virology. 2020;127.
88. CT imaging changes of corona virus disease 2019(COVID-19): A multi-center study in Southwest
China. Li X, Zeng W, Li X, Chen H, Shi L, Li X, et al. Journal of Translational Medicine. 2020;18(1).
89. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. Lillicrap D. Journal of
Thrombosis and Haemostasis. 2020;18(4):786-7.
90. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Lin L, Jiang X, Zhang Z, Huang S,
Zhang Z, Fang Z, et al. Gut. 2020.
91. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Liu X, Li Z, Liu
S, Sun J, Chen Z, Jiang M, et al. Acta pharmaceutica Sinica B. 2020. http://dx.doi.org/10.1016/j.apsb.2020.04.008.
92. Cardiovascular complications in COVID-19. Long B, Brady WJ, Koyfman A, Gottlieb M. American Journal of
Emergency Medicine. 2020.
93. [ACE2 and coronavirus - a question of balance and dynamics?]. Lundstrom A, Sanden P. Lakartidningen.
2020;117.
94. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of
critically ill COVID-19. Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Clinical Immunology. 2020;214.
95. Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest. Mahase E, Kmietowicz Z.
BMJ (Clinical research ed). 2020;368:m1282.
96. The Evolving Pandemic of COVID-19 and Interventional Cardiology. Mahmud E. Catheterization and
Cardiovascular Interventions. 2020.
97. Management of Acute Myocardial Infarction During the COVID-19 Pandemic. Mahmud E, Dauerman
HL, Welt FG, Messenger JC, Rao SV, Grines C, et al. Journal of the American College of Cardiology. 2020.
http://dx.doi.org/10.1016/j.jacc.2020.04.039.
98. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis
(SISET). Marietta M, Ageno W, Artoni A, De Candia E, Gresele P, Marchetti M, et al. Blood transfusion = Trasfusione
del sangue. 2020.
99. EXPRESS: COVID-19 and Stroke - A Global World Stroke Organisation perspective. Markus HS, Brainin
M. International journal of stroke : official journal of the International Stroke Society. 2020:1747493020923472.
http://dx.doi.org/10.1177/1747493020923472.
100. Pulmonary thrombosis in 2019-nCoV pneumonia? Marongiu F, Grandone E, Barcellona D. Journal of
Thrombosis and Haemostasis. 2020.
101. Influence of early use of antimicrobial on the health and performance of Holstein calves in the first
month of life. Martin CC, Basqueira NS, Ramos JS, Silva KN, Baccili CC, Brandão PE, et al. Pesquisa Veterinaria
Brasileira. 2020;40(1):17-28.
102. Primary care management of the coronavirus (Covid-19). Mash B. South African Family Practice.
2020;62(1).
103. Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk. Mattioli AV, Ballerini
Puviani M. American Journal of Lifestyle Medicine. 2020:1559827620918808.
104. Cardiovascular surgery in the COVID-19 pandemic. Mavioglu HL, Unal EU. Journal of cardiac surgery.
2020. http://dx.doi.org/10.1111/jocs.14559.
105. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Meyer P, Degrauwe S, Delden CV,
Ghadri JR, Templin C. European heart journal. 2020.
106. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated
with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of
intravenous lidocaine. Mitra RL, Greenstein SA, Epstein LM. HeartRhythm Case Reports. 2020.
107. Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During
the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective. Morray BH,
Gordon BM, Crystal MA, Goldstein BH, Qureshi AM, Torres AJ, et al. The Journal of invasive cardiology. 2020.
108. Covid-19 nephropathy; an emerging condition caused by novel coronavirus infection. Mubarak M,
Nasri H. Journal of Nephropathology. 2020;9(3).
109. COVID-19 and cardiovascular disorder. Mungmungpuntipantip R, Wiwanitkit V. Minerva
cardioangiologica. 2020. http://dx.doi.org/10.23736/S0026-4725.20.05269-X.
110. All about COVID-19 in brief. Naserghandi A, Allameh SF, Saffarpour R. New Microbes and New Infections.
2020;35.
111. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Nicin L,
Abplanalp WT, Mellentin H, Kattih B, Tombor L, John D, et al. European heart journal. 2020.
112. Mimics and chameleons of COVID-19. Nickel Christian H, Bingisser R. Swiss Medical Weekly. 2020;150(13).
113. COVID-19 and cardiovascular diseases: the facts. Palmer SJ. British Journal of Cardiac Nursing.
2020;15(4):1-3.
114. Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention
and treatment of COVID-19. Pang WT, Jin XY, Pang B, Yang FW, Wang H, Liu CX, et al. Zhongguo Zhong yao za zhi
= Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2020;45(6):1242-7.
115. Clinical presentation and initial management critically ill patients with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. Piva S, Filippini M, Turla F, Cattaneo S, Margola
A, De Fulviis S, et al. Journal of Critical Care. 2020;58:29-33.
116. Vascular Changes Detected With Thoracic CT in Coronavirus Disease (COVID-19) Might Be Significant
Determinants for Accurate Diagnosis and Optimal Patient Management. Qanadli SD, Beigelman-Aubry C,
Rotzinger DC. AJR American journal of roentgenology. 2020:W1.
117. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With
COVID-19 in the New York City Area. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW,
et al. Jama. 2020. http://dx.doi.org/10.1001/jama.2020.6775.
118. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic. Robert Denniss A, Chow CK,
Kritharides L. Heart Lung and Circulation. 2020.
119. Explanation for COVID-19 infection neurological damage and reactivations. Roe K. Transboundary and
emerging diseases. 2020. http://dx.doi.org/10.1111/tbed.13594.
120. Coronavirus disease 2019 infection and the cardiovascular system. Romeo F, Calcaterra G, Barilla F,
Mehta JL. Journal of cardiovascular medicine (Hagerstown, Md). 2020.
http://dx.doi.org/10.2459/JCM.0000000000000980.
121. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term
outcome. Roncon L, Zuin M, Rigatelli G, Zuliani G. Journal of Clinical Virology. 2020;127.
122. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed
tomography. Rotzinger DC, Beigelman-Aubry C, von Garnier C, Qanadli SD. Thrombosis Research. 2020;190:58-9.
123. Performance of Electrophysiology Procedures at an Academic Medical Center Amidst the 2020
Coronavirus (COVID-19) Pandemic. Rubin GA, Biviano A, Dizon J, Yarmohammadi H, Ehlert F, Saluja D, et al. Journal
of cardiovascular electrophysiology. 2020.
124. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in
COVID-19. Ryan PM, Caplice NM. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22843.
125. Immediate and Near Future Prediction of COVID-19 Patients in the U.S. Population Aged 65+ With
the Prior Medical Conditions of Hypertension, Cardiovascular and Lung Diseases: Methods, Models and Acute
Care Estimates. S.R. Srinivasa Rao A, Miller D, Berman A, Hess D, Krantz S. Journal. 2020(Issue).
126. Angiotensin receptor blockers and COVID-19. Saavedra JM. Pharmacological Research. 2020;156.
127. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2
respiratory infection. Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. European heart
journal. 2020.
128. Implications for forensic death investigations from first Swiss post-mortem CT in a case of
non-hospital treatment with COVID-19. Schweitzer W, Ruder T, Baumeister R, Bolliger S, Thali M, Meixner E, et al.
Forensic Imaging. 2020;21.
129. [ANMCO Position paper: The network organization for the management of patients with acute
coronary syndrome during the COVID-19 pandemic]. Scotto Di Uccio F, Valente S, Colivicchi F, Murrone A,
Caldarola P, Di Lenarda A, et al. Giornale italiano di cardiologia (2006). 2020;21(5):332-5.
http://dx.doi.org/10.1714/3343.33129.
130. The other side of novel coronavirus outbreak: Fear of performing cardiopulmonary resuscitation.
Scquizzato T, Olasveengen TM, Ristagno G, Semeraro F. Resuscitation. 2020;150:92-3.
131. The need for neurologists in the care of COVID-19 patients. Sellner J, Taba P, Ozturk S, Helbok R. Eur J
Neurol. 2020. http://dx.doi.org/10.1111/ene.14257.
132. Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic
Review and Meta-analysis. Shamshirian A, Heydari K, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Hessami A.
medRxiv. 2020:2020.04.12.20062869.
133. COVID-19 and intracerebral haemorrhage: causative or coincidental? Sharifi-Razavi A, Karimi N, Rouhani
N. New Microbes and New Infections. 2020;35.
134. Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke during COVID-19
Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC).
Sharma D, Rasmussen M, Han R, Whalin M, Davis M, Kofke WA, et al. Journal of Neurosurgical Anesthesiology. 2020.
135. Covid-19: The outbreak caused by a new coronavirus. Sifuentes-Rodríguez E, Palacios-Reyes D. Boletin
Medico del Hospital Infantil de Mexico. 2020;77(2):47-53.
136. Could COVID-19 represents a negative prognostic factor in patients with stroke? Siniscalchi A, Gallelli L.
Infect Control Hosp Epidemiol. 2020:1-4. http://dx.doi.org/10.1017/ice.2020.146.
137. Zinc and respiratory tract infections: Perspectives for COVID19 (Review). Skalny AV, Rink L, Ajsuvakova
OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. International journal of molecular medicine. 2020.
http://dx.doi.org/10.3892/ijmm.2020.4575.
138. Concerns for Active Breathing Control (ABC) With Breast Cancer in the Era of COVID-19: Maximizing
Infection Control While Minimizing Heart Dose. Song AJ, Manukian G, Taylor AK, Anne PR, Simone NL. Advances in
Radiation Oncology. 2020.
139. Emerging 2019 novel coronavirus (2019-NCoV) pneumonia. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H,
et al. Radiology. 2020;295(1):210-7.
140. Recommendations on cardiopulmonary resuscitation strategy and procedure for novel coronavirus
pneumonia. Song W, Liu Y, Ouyang Y, Chen W, Li M, Xianyu S, et al. Resuscitation. 2020.
141. Lessons from covid-19: Visiting patients at home and assessing comorbidities. Stevens AMH. The BMJ.
2020;369.
142. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Su H,
Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Kidney International. 2020.
143. Response and Operating Room Preparation for the COVID-19 Outbreak: A Perspective From the
National Heart Centre in Singapore. Tan Z, Phoon PHY, Zeng LA, Fu J, Lim XT, Tan TE, et al. Journal of
Cardiothoracic and Vascular Anesthesia. 2020.
144. Reply to the comment. Tang N. Journal of thrombosis and haemostasis : JTH. 2020.
145. [Being a cardiologist at the time of SARS-COVID-19: is it time to reconsider our way of working?].
Tarantini L, Navazio A, Cioffi G, Turiano G, Colivicchi F, Gabrielli D. Giornale italiano di cardiologia (2006).
2020;21(5):354-7. http://dx.doi.org/10.1714/3343.33133.
146. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Tavazzi G, Pellegrini C, Maurelli
M, Belliato M, Sciutti F, Bottazzi A, et al. European journal of heart failure. 2020.
147. DOACs and 'newer' haemophilia therapies in COVID-19. Thachil J, Tang N, Gando S, Falanga A, Cattaneo
M, Levi M, et al. Journal of thrombosis and haemostasis : JTH. 2020.
148. Cardiovascular emergencies in the COVID-19 pandemic. Thiele H. Herz. 2020.
http://dx.doi.org/10.1007/s00059-020-04931-1.
149. [ANMCO Position paper: Considerations on in-hospital cardiological consultations and cardiology
outpatient clinics during the COVID-19 pandemic]. Valente S, Colivicchi F, Caldarola P, Murrone A, Di Lenarda A,
Roncon L, et al. Giornale italiano di cardiologia (2006). 2020;21(5):341-4. http://dx.doi.org/10.1714/3343.33131.
150. Doing the right thing for the right reason when treating ruptured abdominal aortic aneurysms in the
COVID-19 era. Verikokos C, Lazaris AM, Geroulakos G. Journal of vascular surgery. 2020.
151. [COVID-19 and coronary artery disease: selective and collaborative use of resources during public
health crisis]. Villa E, Saccocci M, Messina A, Maffeo D, Piti A, Bianchetti F, et al. Giornale italiano di cardiologia
(2006). 2020;21(5):360-3. http://dx.doi.org/10.1714/3343.33135.
152. [Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement
of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology]. Vivas D, Roldan V,
Esteve-Pastor MA, Roldan I, Tello-Montoliu A, Ruiz-Nodar JM, et al. Revista espanola de cardiologia. 2020.
http://dx.doi.org/10.1016/j.recesp.2020.04.006.
153. Current data on the cardiovascular effects of the COVID-19. Vlachakis PK, Tentolouris A, Tousoulis D,
Tentolouris N. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2020.
http://dx.doi.org/10.1016/j.hjc.2020.04.001.
154. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.
Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. The Lancet Haematology. 2020.
155. Research Article Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with
Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Wang X, Fang
X, Cai Z, Wu X, Gao X, Min J, et al.
156. Obesity and SARS-CoV-2: a population to safeguard. Watanabe M, Risi R, Tuccinardi D, Baquero CJ,
Manfrini S, Gnessi L. Diabetes Metab Res Rev. 2020:e3325. http://dx.doi.org/10.1002/dmrr.3325.
157. [Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man]. Wissenberg M,
Andersen LPK, Pallisgaard JL, Lawson-Smith P. Ugeskrift for laeger. 2020;182(16).
158. Plasminogen improves lung lesions and hypoxemia in patients with COVID-19. Wu Y, Wang T, Guo C,
Zhang D, Ge X, Huang Z, et al. QJM : monthly journal of the Association of Physicians. 2020.
159. Emergency Caesarean delivery in a patient with confirmed COVID-19 under spinal anaesthesia. Xia H,
Zhao S, Wu Z, Luo H, Zhou C, Chen X. British Journal of Anaesthesia. 2020;124(5):e216-e8.
160. [Research advances in cardiovascular system damage caused by SARS-CoV-2 in children]. Xiao HH,
Wang X, Xu Y, Wang C. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(4):299-304.
161. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based
Practice. Xu G, Yang Y, Du Y, Peng F, Hu P, Wang R, et al. Clinical reviews in allergy & immunology. 2020.
http://dx.doi.org/10.1007/s12016-020-08792-8.
162. Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2:
A double-edged sword? Yan T, Xiao R, Lin G. FASEB journal : official publication of the Federation of American
Societies for Experimental Biology. 2020. http://dx.doi.org/10.1096/fj.202000782.
163. Analysis of 92 deceased patients with COVID-19. Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Journal of
medical virology. 2020.
164. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review
and meta-analysis. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. International Journal of Infectious Diseases.
2020;94:91-5.
165. Taipei Azalea – Supraglottic airways (SGA) preassembled with high-efficiency particulate air (HEPA)
filters to simplify prehospital airway management for patients with out-of-hospital cardiac arrests (OHCA)
during Coronavirus Disease 2019 (COVID-19) pandemic. Yang WS, Hou SW, Lee BC, Chiang WC, Chien YC, Chen
SY, et al. Resuscitation. 2020;151:3-5.
166. Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients. Yao
Q, Wang P, Wang X, Qie G, Meng M, Tong X, et al. Polish archives of internal medicine. 2020.
http://dx.doi.org/10.20452/pamw.15312.
167. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and
international expert recommendations. Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. British Journal of
Anaesthesia. 2020.
168. Symptom Cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan, China. Yifan T, Ying
L, Chunhong G, Jing S, Rong W, Zhenyu L, et al. Journal of pain and symptom management. 2020.
169. Surgical operations during the COVID-19 outbreak: Should elective surgeries be suspended? Zarrintan
S. International Journal of Surgery. 2020;78:5-6.
170. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Zeng JH,
Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. Infection. 2020.
171. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on
the scene' cardiologists. Zhang L, Fan Y, Lu Z. European heart journal. 2020.
172. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty
liver disease. Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, et al. Metabolism: clinical and experimental.
2020:154244. http://dx.doi.org/10.1016/j.metabol.2020.154244.
173. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with
2019 novel coronavirus disease: a case report. Zhou B, She J, Wang Y, Ma X. J Thromb Thrombolysis. 2020.
http://dx.doi.org/10.1007/s11239-020-02084-w.
174. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host
Immune Response. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Current cardiology reports.
2020;22(5):32. http://dx.doi.org/10.1007/s11886-020-01292-3.
175. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Zhu H, Wang L, Fang C,
Peng S, Zhang L, Chang G, et al. Translational Pediatrics. 2020;9(1):51-60.
176. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.
Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, et al. International journal of infectious diseases : IJID : official publication
of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.04.041.
Literatuuroverzicht tot 23-04-2020
1. [Expert consensus on principal of clinical management of patients with severe emergent
cardiovascular diseases during the epidemic period of COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi.
2020;48(3):189-94. http://dx.doi.org/10.3760/cma.j.cn112148-20200210-00066.
2. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients
with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morbidity and mortality
weekly report. 2020;69(13):382-6. http://dx.doi.org/10.15585/mmwr.mm6913e2.
3. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. Stroke. 2020.
http://dx.doi.org/10.1161/STROKEAHA.120.030023.
4. [Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular
disease and COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E014.
http://dx.doi.org/10.3760/cma.j.issn.0253-3758.2020.0014.
5. Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to
SARS-CoV-2-related cardiovascular complications. Abassi Z, Assady S, Khoury EE, Heyman SN. American journal of
physiology Heart and circulatory physiology. 2020;318(5):H1080-h3. http://dx.doi.org/10.1152/ajpheart.00215.2020.
Epub 2020 Mar 30.
6. Angiotensin converting enzyme 2 - An ally or a Trojan horse? Implications to SARS-CoV-2 -related
cardiovascular complications. Abassi ZA, Assady S, Khoury EE, Heyman SN. American journal of physiology Heart
and circulatory physiology. 2020. http://dx.doi.org/10.1152/ajpheart.00215.2020.
7. Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies
against COVID-19. Abdullahi IN, Emeribe AU, Mustapha JO, Fasogbon SA, Ofor IB, Opeyemi IS, et al. Le infezioni in
medicina. 2020;28(2):166-73.
8. Haemophilus parainfluenzae endocarditis with multiple cerebral emboli and infarcts in a young
pregnant woman. Abu-Hishmeh M, Martin A, DeCastro A, Paul L. American Journal of Respiratory and Critical Care
Medicine. 2019;199(9).
9. Inside the heart of COVID-19. Adao R. Cardiovascular research. 2020.
http://dx.doi.org/10.1093/cvr/cvaa086.
10. The risk factors associated with MERS-CoV patient fatality: A global survey. Ahmadzadeh J, Mobaraki K,
Mousavi SJ, Aghazadeh-Attari J, Mirza-Aghazadeh-Attari M, Mohebbi I. Diagnostic Microbiology and Infectious
Disease. 2020;96(3).
11. COVID-19 and the Heart. Akhmerov A, Marban E. Circ Res. 2020.
http://dx.doi.org/10.1161/CIRCRESAHA.120.317055.
12. [Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What
cardiologists should know. (25th March 2020)]. Aktoz M, Altay H, Aslanger E, Atalar E, Aytekin V, Baykan AO, et al.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2020;48:1-48.
http://dx.doi.org/10.5543/tkda.2020.97198.
13. Middle east respiratory syndrome coronavirus (Mers-cov) in Oman: Current situation and going
forward. Al Awaidy ST, Khamis F. Oman Medical Journal. 2019;34(3):181-3.
14. Diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi
Arabia. Alanazi KH, Abedi GR, Midgley CM, Alkhamis A, Alsaqer T, Almoaddi A, et al. Emerging Infectious Diseases.
2020;26(1):166-8.
15. Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory
syndrome-coronavirus infections: A 4-year experience from a tertiary care center. Al-Baadani A, Elzein F,
Alhemyadi S, Khan O, Albenmousa A, Idrees M. Annals of Thoracic Medicine. 2019;14(3):179-85.
16. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An
uncommon radiological presentation. Albarello F, Pianura E, Di Stefano F, Cristofaro M, Petrone A, Marchioni L, et
al. International Journal of Infectious Diseases. 2020;93:192-7.
17. Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable
patients. Alburikan KA, Abuelizz HA. Saudi Pharmaceutical Journal. 2020;28(2):161-4.
18. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of
two cases & review of the literature. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Journal of Microbiology, Immunology
and Infection. 2019;52(3):501-3.
19. The Role of Data Registries in the Time of COVID-19. Alger HM, Williams Iv JH, Walchok JG, Bolles MM,
Fonarow GC, Rutan C. Circulation Cardiovascular quality and outcomes. 2020.
http://dx.doi.org/10.1161/CIRCOUTCOMES.120.006766.
20. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From
Cardiovascular Aging Science. AlGhatrif M, Cingolani O, Lakatta EG. JAMA Cardiol. 2020.
http://dx.doi.org/10.1001/jamacardio.2020.1329.
21. Descriptive Epidemiology, Clinical Characteristics and Outcomes for Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) Infected Patients in AlAin – Abu Dhabi Emirate. Alkendi F, Nair SC, Hashmey
R. Journal of Infection and Public Health. 2019;12(1):137.
22. SAT-028 ACUTE KIDNEY INJURY ASSOCIATED WITH MIDDLE EAST RESPIRATORY SYNDROME
CORONAVIRUS (MERS-CoV) INFECTION. Alkindi F, Boobes Y, Chandrasekhar Nair S, Hashmey R. Kidney
International Reports. 2020;5(3):S13.
23. Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: A retrospective
study. Alqahtani FY, Aleanizy FS, Ali El Hadi Mohamed R, Alanazi MS, Mohamed N, Alrasheed MM, et al. Epidemiology
and Infection. 2019;147.
24. Estimation of direct medical costs of middle east respiratory syndrome coronavirus infection: A
single-center retrospective chart review study. AlRuthia Y, Somily AM, Alkhamali AS, Bahari OH, Aljuhani RJ,
Alsenaidy M, et al. Infection and Drug Resistance. 2019;12:3463-73.
25. Drugs and the renin-angiotensin system in covid-19. Aronson JK, Ferner RE. Bmj. 2020;369:m1313.
http://dx.doi.org/10.1136/bmj.m1313.
26. Case Report: A Kidney Transplant Patient with Mild COVID-19. Arpali E, Akyollu B, Yelken B, Tekin S,
Turkmen A, Kocak B. Transplant infectious disease : an official journal of the Transplantation Society. 2020:e13296.
http://dx.doi.org/10.1111/tid.13296.
27. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and
Other Clinical Manifestations and Potential Therapeutic Strategies. Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow
DA, Bohula EA. JACC Basic to translational science. 2020. http://dx.doi.org/10.1016/j.jacbts.2020.04.002.
28. SALIVA IS A RELIABLE TOOL TO DETECT SARS-CoV-2. Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina
DD, Genoni A, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.005.
29. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a
possible strategy for reducing SARS-COV-2 infectivity? Baglivo M, Baronio M, Natalini G, Beccari T, Chiurazzi P,
Fulcheri E, et al. Acta bio-medica : Atenei Parmensis. 2020;91(1):161-4.
30. Cardiovascular disease and COVID-19. Bansal M. Diabetes & Metabolic Syndrome: Clinical Research &
Reviews. 2020.
31. Acute stroke management pathway during Coronavirus-19 pandemic. Baracchini C, Pieroni A, Viaro F,
Cianci V, Cattelan AM, Tiberio I, et al. Neurological sciences : official journal of the Italian Neurological Society and of
the Italian Society of Clinical Neurophysiology. 2020. http://dx.doi.org/10.1007/s10072-020-04375-9.
32. Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. Baradaran
A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. The Archives of Bone and Joint Surgery. 2020;8:0-.
33. SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria. Barrasa H, Rello
J, Tejada S, Martin A, Balziskueta G, Vinuesa C, et al. Anaesthesia, critical care & pain medicine. 2020.
http://dx.doi.org/10.1016/j.accpm.2020.04.001.
34. COVID-19 Autopsies, Oklahoma, USA. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S.
American journal of clinical pathology. 2020. http://dx.doi.org/10.1093/ajcp/aqaa062.
35. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Bassetti M,
Vena A, Giacobbe DR. European Journal of Clinical Investigation. 2020;50(3).
36. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? Battistoni A, Volpe M.
European heart journal Cardiovascular pharmacotherapy. 2020. http://dx.doi.org/10.1093/ehjcvp/pvaa030.
37. COVID-19: towards controlling of a pandemic. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C,
Kobinger G, et al. Lancet. 2020;395(10229):1015-8. http://dx.doi.org/10.1016/S0140-6736(20)30673-5. Epub 2020 Mar
17.
38. Critically ill influenza patients-co-infections and cardiovascular events. Begot E, Prevel R, Camou F,
Picard W, Gisbert-Mora C, Boyer A, et al. Annals of Intensive Care. 2019;9.
39. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in
India: Protocol for restricted public health emergency use. Bhatnagar T, Murhekar MV, Soneja M, Gupta N, Giri S,
Wig N, et al. The Indian journal of medical research. 2020.
40. SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners.
Biondi-Zoccai G, Landoni G, Carnevale R, Cavarretta E, Sciarretta S, Frati G. Minerva cardioangiologica. 2020.
41. Etiology of community-acquired pneumonia in patients with chronic heart failure. Bobylev AA, Rachina
SA, Avdeev SN, Kozlov RS, Sukhorukova MV, Yatsyshina SB, et al. Pulmonologiya. 2019;29(3):293-301.
42. [Coronavirus: the geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of
the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology]. Bonanad C,
Garcia-Blas S, Tarazona-Santabalbina FJ, Diez-Villanueva P, Ayesta A, Fores JS, et al. Revista espanola de cardiologia.
2020. http://dx.doi.org/10.1016/j.recesp.2020.03.027.
43. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2.
Buckley LF, Cheng JWM, Desai A. Journal of cardiovascular pharmacology. 2020.
http://dx.doi.org/10.1097/FJC.0000000000000840.
44. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in
patients with hypertension? Cadegiani FA. American journal of physiology Endocrinology and metabolism.
2020;318(5):E587-e8. http://dx.doi.org/10.1152/ajpendo.00136.2020.
45. Theoretical basis and effect characteristics of andrographolide against COVID-19. Cai N, Li YJ, Zhou GR,
Xin C, Xie J, Zhou HH, et al. Chinese Traditional and Herbal Drugs. 2020;51(5):1159-66.
46. Antirheumatic agents in covid-19: is IL-6 the right target? Capecchi PL, Lazzerini PE, Volterrani L, Mazzei
MA, Rossetti B, Zanelli G, et al. Ann Rheum Dis. 2020. http://dx.doi.org/10.1136/annrheumdis-2020-217523.
47. Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss
consensus statement by the Working Party Hemostasis. Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber
B, Graf L, et al. Swiss medical weekly. 2020;150:w20247. http://dx.doi.org/10.4414/smw.2020.20247. eCollection 2020
Apr 6.
48. Analysis of myocardial injury in patients with COVID-19 and association between concomitant
cardiovascular diseases and severity of COVID-19. Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. Zhonghua xin xue
guan bing za zhi. 2020;48:E008.
49. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Chen C, Zhou Y, Wang DW. Herz.
2020.
50. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular
disease. Chen L, Hao G. Cardiovascular research. 2020. http://dx.doi.org/10.1093/cvr/cvaa093.
51. The ACE2 expression in human heart indicates new potential mechanism of heart injury among
patients infected with SARS-CoV-2. Chen L, Li X, Chen M, Feng Y, Xiong C. Cardiovascular research. 2020.
http://dx.doi.org/10.1093/cvr/cvaa078.
52. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing
Cesarean delivery: a case series of 17 patients. Chen R, Zhang Y, Huang L, Cheng BH, Xia ZY, Meng QT. Canadian
Journal of Anesthesia. 2020.
53. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Bmj. 2020;368:m1091. http://dx.doi.org/10.1136/bmj.m1091.
54. Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of
COVID-19. Cheng H, Wang Y, Wang GQ. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25785.
55. Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that
is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in
cardiovascular disease. Is this just a phylogenetic coincidence? Ciulla MM. Journal of Medical Virology. 2020.
56. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Clerkin KJ, Fried JA, Raikhelkar J,
Sayer G, Griffin JM, Masoumi A, et al. Circulation. 2020.
57. Impact, Strategies and Opportunities for Early and Mid-Career Cardiovascular Researchers During the
COVID-19 Pandemic. Climie RE, Marques FZ. Circulation. 2020.
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047394.
58. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
Conti P, Younes A. Journal of biological regulators and homeostatic agents. 2020;34(2).
http://dx.doi.org/10.23812/Editorial-Conti-3.
59. A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and
heart damage. Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. The Journal of infectious diseases. 2020.
60. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to
Abandon Renin-Angiotensin System Blockers. Danser AHJ, Epstein M, Batlle D. Hypertension (Dallas, Tex : 1979).
2020:Hypertensionaha12015082. http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15082.
61. A multicenter consortium to define the epidemiology and outcomes of pediatric solid organ
transplant recipients with inpatient respiratory virus infection. Danziger-Isakov L, Steinbach WJ, Paulsen G,
Munoz FM, Sweet LR, Green M, et al. Journal of the Pediatric Infectious Diseases Society. 2019;8(3):197-204.
62. Haemophilus parainfluenzae endocarditis with multiple cerebral emboli in a pregnant woman with
coronavirus. De Castro A, Abu-Hishmeh M, El Husseini I, Paul L. IDCases. 2019;18.
63. Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during
the COVID-19 pandemic. DeBaun MR. Blood. 2020. http://dx.doi.org/10.1182/blood.2020005992.
64. Adapting the Educational Environment for Cardiovascular Fellows-in-Training During the COVID-19
Pandemic. DeFilippis EM, Stefanescu Schmidt AC, Reza N. Journal of the American College of Cardiology. 2020.
http://dx.doi.org/10.1016/j.jacc.2020.04.013.
65. The GReek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19
study): rationale and study design. Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG,
et al. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2020.
http://dx.doi.org/10.1016/j.hjc.2020.03.002.
66. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation
in Wuhan, China. Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, et al. Int J Cardiol. 2020.
http://dx.doi.org/10.1016/j.ijcard.2020.03.087.
67. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China.
Deng SQ, Peng HJ. Journal of Clinical Medicine. 2020;9(2).
68. COVID-19 coronavirus: What implications for cardiology? Di Pasquale G. Giornale Italiano di Cardiologia.
2020;21(4):243-5.
69. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may
increase the risk of severe COVID-19. Diaz JH. Journal of travel medicine. 2020.
70. Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19). Dixon DL, Van Tassell
BW, Vecchie A, Bonaventura A, Talasaz A, Kakavand H, et al. Journal of cardiovascular pharmacology. 2020.
http://dx.doi.org/10.1097/FJC.0000000000000836.
71. A not so common cold-a case of acute respiratory distress syndrome due to adenovirus-associated
pneumonia. Dogra M, Sander P, Yalamanchili R. American Journal of Respiratory and Critical Care Medicine.
2019;199(9).
72. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the
Coronavirus Disease 2019 (COVID-19) Pandemic. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J,
Bondi-Zoccai G, et al. Journal of the American College of Cardiology. 2020.
73. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Drucker DJ.
Endocrine reviews. 2020. http://dx.doi.org/10.1210/endrev/bnaa011.
74. Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective
Cohort Study. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. The European respiratory journal. 2020.
http://dx.doi.org/10.1183/13993003.00524-2020.
75. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. Du
Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Am J Respir Crit Care Med. 2020.
http://dx.doi.org/10.1164/rccm.202003-0543OC.
76. Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With
Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the
Guidelines((R))-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in
Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American
College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of
Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS
Physicians. Edelson DP, Sasson C, Chan PS, Atkins DL, Aziz K, Becker LB, et al. Circulation. 2020.
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047463.
77. [COVID-19 pandemia: Impact on the cariovascular system. Data of 1(st) April 2020]. El Boussadani B,
Benajiba C, Aajal A, Ait Brik A, Ammour O, El Hangouch J, et al. Annales de cardiologie et d'angeiologie. 2020.
http://dx.doi.org/10.1016/j.ancard.2020.04.001.
78. Role of the American Heart Association in the Global COVID-19 Pandemic. Elkind MS, Harrington RA,
Benjamin IJ. Circulation. 2020.
79. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and
Meta-Analysis. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Arch Acad Emerg Med. 2020;8(1):e35.
80. Call to action for the cardiovascular side of COVID-19. Emanueli C, Badimon L, Martelli F, Potocnjak I,
Carpusca I, Robinson EL, et al. European heart journal. 2020. http://dx.doi.org/10.1093/eurheartj/ehaa301.
81. Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported
from Italy and Spain. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcon-De-la-Vega G,
Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Travel Med Infect Dis. 2020:101653.
http://dx.doi.org/10.1016/j.tmaid.2020.101653.
82. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? Esler M, Esler
D. Journal of hypertension. 2020;38(5):781-2. http://dx.doi.org/10.1097/HJH.0000000000002450.
83. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Fang L,
Karakiulakis G, Roth M. The Lancet Respiratory Medicine. 2020.
84. Novel coronavirus (2019-nCoV) update: What we know and what is unknown. Fasina F. Asian Pacific
Journal of Tropical Medicine. 2020;13(3):97-8.
85. Hiding in plain sight: An approach to treating patients with severe covid-19 infection. Fedson DS, Opal
SM, Rordam OM. mBio. 2020;11(2).
86. Commentary: What is the relationship between Covid-19 and cardiovascular disease? Ferrari R, Di
Pasquale G, Rapezzi C. Int J Cardiol. 2020. http://dx.doi.org/10.1016/j.ijcard.2020.03.074.
87. 2019 CORONAVIRUS: What are the implications for cardiology? Ferrari R, Di Pasquale G, Rapezzi C.
European journal of preventive cardiology. 2020:2047487320918102.
88. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with
Gastroenteritis and Developing Severe Pulmonary Disease. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E,
Ivaturi K, et al. Am J Nephrol. 2020:1-6. http://dx.doi.org/10.1159/000507417.
89. Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations from Society for
Neuroscience in Anesthesiology & Critical Care (SNACC). Flexman AM, Abcejo A, Avitisian R, De Sloovere V,
Highton D, Juul N, et al. Journal of neurosurgical anesthesiology. 2020.
http://dx.doi.org/10.1097/ANA.0000000000000691.
90. Cardiovascular molecular mechanisms of disease with COVID-19. Foo R, Wang Y, Zimmermann WH,
Backs J, Wang DW. J Mol Cell Cardiol. 2020. http://dx.doi.org/10.1016/j.yjmcc.2020.04.010.
91. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. Fox SE,
Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. medRxiv. 2020:2020.04.06.20050575.
92. Society of NeuroInterventional Surgery recommendations for the care of emergent
neurointerventional patients in the setting of covid-19. Fraser JF, Arthur AS, Chen M, Levitt M, Mocco J,
Albuquerque FC, et al. Journal of neurointerventional surgery. 2020.
http://dx.doi.org/10.1136/neurintsurg-2020-016098.
93. The Variety of Cardiovascular Presentations of COVID-19. Fried JA, Ramasubbu K, Bhatt R, Topkara VK,
Clerkin KJ, Horn E, et al. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047164.
94. The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and
Cancer. Ganatra S, Hammond SP, Nohria A. Journal. 2020(Issue).
95. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed
Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. Garg S, Kim L, Whitaker M, O'Halloran A,
Cummings C, Holstein R, et al. MMWR Morbidity and mortality weekly report. 2020;69(15):458-64.
http://dx.doi.org/10.15585/mmwr.mm6915e3.
96. Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin
System. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Circ Res. 2020.
http://dx.doi.org/10.1161/CIRCRESAHA.120.317015.
97. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of
glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using
multivariate regression analysis. Ghosal S, Sinha B, Majumder M, Misra A. Diabetes & metabolic syndrome.
2020;14(4):319-23. http://dx.doi.org/10.1016/j.dsx.2020.03.014.
98. The first two cases of 2019-nCoV in Italy: Where they come from? Giovanetti M, Benvenuto D, Angeletti
S, Ciccozzi M. J Med Virol. 2020;92(5):518-21. http://dx.doi.org/10.1002/jmv.25699. Epub 2020 Feb 12.
99. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could
lead to overlapping treatments. Gonzalez-Jaramillo N, Low N, Franco OH. European journal of epidemiology. 2020.
http://dx.doi.org/10.1007/s10654-020-00628-1.
100. Novel findings from a beta coronavirus outbreak on an American Miniature Horse breeding farm in
upstate New York. Goodrich EL, Mittel LD, Glaser A, Ness SL, Radcliffe RM, Divers TJ. Equine Veterinary Education.
2020;32(3):150-4.
101. Perspective: cardiovascular disease and the Covid-19 pandemic. Gori T, Lelieveld J, Munzel T. Basic
research in cardiology. 2020;115(3):32. http://dx.doi.org/10.1007/s00395-020-0792-4.
102. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies
are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. Gorse GJ,
Donovan MM, Patel GB. Journal of Medical Virology. 2020;92(5):512-7.
103. Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? Gracia-Ramos AE. Archives of medical
research. 2020. http://dx.doi.org/10.1016/j.arcmed.2020.03.011.
104. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs
of the Lombardy Region, Italy. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Jama. 2020.
http://dx.doi.org/10.1001/jama.2020.5394.
105. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Guan WJ,
Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. The European respiratory journal. 2020.
http://dx.doi.org/10.1183/13993003.00547-2020.
106. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential
Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity
of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Guo J, Huang Z, Lin L, Lv J. Journal of the
American Heart Association. 2020;9(7):e016219. http://dx.doi.org/10.1161/JAHA.120.016219. Epub 2020 Apr 1.
107. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. JAMA Cardiol. 2020.
http://dx.doi.org/10.1001/jamacardio.2020.1017.
108. Contentious issues and evolving concepts in the clinical presentation and management of patients
with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases
(Hypertension, diabetes etc). Gupta R, Misra A. Diabetes & metabolic syndrome. 2020;14(3):251-4.
http://dx.doi.org/10.1016/j.dsx.2020.03.012.
109. [COVID-19 andcardiovascular diseases]. Haeck G, Ancion A, Marechal P, Oury C, Lancellotti P. Revue
medicale de Liege. 2020;75(4):226-32.
110. Middle East respiratory syndrome coronavirus, Saudi Arabia, 2017-2018. Hakawi A, Rose EB, Biggs HM,
Lu X, Mohammed M, Abdalla O, et al. Emerging Infectious Diseases. 2019;25(11):2149-51.
111. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan,
China. Han H, Xie L, Liu R, Yang J, Liu F, Wu K, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25809.
112. CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent
Cardiovascular Diseases during the COVID-19 Epidemic. Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X, et al.
Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047011.
113. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for
Epidemiologic Investigations. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Clin Infect Dis. 2020.
http://dx.doi.org/10.1093/cid/ciaa329.
114. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon.
Haslak F, Yildiz M, Adrovic A, Barut K, Kasapcopur O. Balkan medical journal. 2020.
http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2020.4.43.
115. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19
patients. He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, et al. Zhonghua xin xue guan bing za zhi. 2020;48:E011.
116. Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical
Patients With Suspected or Confirmed Coronavirus Disease 2019. He Y, Wei J, Bian J, Guo K, Lu J, Mei W, et al. J
Cardiothorac Vasc Anesth. 2020. http://dx.doi.org/10.1053/j.jvca.2020.03.026.
117. Covid-19 outbreak measures may indirectly lead to greater burden on hospitals. Heckman GA, Saari M,
McArthur C, Wellens NIH, Hirdes JP. CMAJ. 2020;192(14):E384.
118. Risks and benefits of bronchoscopy during the first 100 days following allogeneic hematopoietic cell
transplantation. Hefazi M, Sakemura R, Kenderian SS, Patnaik MM, Hogan WJ, Litzow M, et al. Blood. 2019;134.
119. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Hendren
NS, Drazner MH, Bozkurt B, Cooper LT, Jr. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047349.
120. First case of 2019 novel coronavirus in the United States. Holshue ML, DeBolt C, Lindquist S, Lofy KH,
Wiesman J, Bruce H, et al. New England Journal of Medicine. 2020;382(10):929-36.
121. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Hu H, Ma
F, Wei X, Fang Y. European heart journal. 2020.
122. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and
meta-analysis. Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Journal of Clinical Virology. 2020:104371.
123. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y,
Li X, Ren L, Zhao J, Hu Y, et al. The Lancet. 2020;395(10223):497-506.
124. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19. Huang
Z, Jiang Y, Chen J, Zhou Y. Cardiology journal. 2020. http://dx.doi.org/10.5603/CJ.a2020.0056.
125. COVID-19 in patients with cardiovascular diseases. Hulot JS. Arch Cardiovasc Dis. 2020.
http://dx.doi.org/10.1016/j.acvd.2020.03.009.
126. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado
for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian
Society of Hypertension. Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. High blood pressure
& cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2020.
http://dx.doi.org/10.1007/s40292-020-00380-3.
127. Outcome of Oncology Patients Infected With Coronavirus. Jazieh AR, Alenazi TH, Alhejazi A, Al Safi F, Al
Olayan A. JCO global oncology. 2020;6:471-5. http://dx.doi.org/10.1200/GO.20.00064.
128. Porcine deltacoronavirus activates the Raf/MEK/ERK pathway to promote its replication. Jeon JH, Jin
Lee Y, Lee C. Virus Res. 2020:197961. http://dx.doi.org/10.1016/j.virusres.2020.197961.
129. Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Ji HL, Zhao R, Matalon S,
Matthay MA. Physiological reviews. 2020. http://dx.doi.org/10.1152/physrev.00013.2020.
130. Frequency of arrhythmia in novel coronavirus 2019 infection. Joob B, Wiwanitkit V. Journal of
Arrhythmia. 2020.
131. Mapping Viral Susceptibility Loci in Mice. Kane M, Golovkina TV. Annual Review of Virology.
2019;6:525-46.
132. Mortality rate of infection with COVID-19 in Korea from the perspective of underlying disease. Kang
YJ. Disaster medicine and public health preparedness. 2020:1-6. http://dx.doi.org/10.1017/dmp.2020.60.
133. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A
scientific statement from the Indian Heart Rhythm Society. Kapoor A, Pandurangi U, Arora V, Gupta A, Jaswal A,
Nabar A, et al. Indian pacing and electrophysiology journal. 2020. http://dx.doi.org/10.1016/j.ipej.2020.04.003.
134. Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019
(COVID-19) Pandemic. Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Stroke.
2020:Strokeaha120029838. http://dx.doi.org/10.1161/STROKEAHA.120.029838.
135. The 2019 Novel Coronavirus Outbreak - A Global Threat. Khot WY, Nadkar MY. The Journal of the
Association of Physicians of India. 2020;68(3):67-71.
136. Human saliva: Non-invasive fluid for detecting novel coronavirus (2019-nCoV). Khurshid Z, Asiri FYI, Al
Wadaani H. International Journal of Environmental Research and Public Health. 2020;17(7).
137. Sequential emergence and wide spread of neutralization escape middle east respiratory syndrome
coronavirus mutants, South Korea, 2015. Kim YS, Aigerim A, Park U, Kim Y, Rhee JY, Choi JP, et al. Emerging
Infectious Diseases. 2019;25(6):1161-8.
138. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Klok FA, Kruip M, van
der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Thromb Res. 2020.
http://dx.doi.org/10.1016/j.thromres.2020.04.013.
139. Wearable Cardiorespiratory Monitoring Employing a Multimodal Digital Patch Stethoscope:
Estimation of ECG, PEP, LVETand Respiration Using a 55 mm Single-Lead ECG and Phonocardiogram. Klum M,
Urban M, Tigges T, Pielmus AG, Feldheiser A, Schmitt T, et al. Sensors (Basel, Switzerland). 2020;20(7).
http://dx.doi.org/10.3390/s20072033.
140. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Kow CS, Zaidi
STR, Hasan SS. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2020.
http://dx.doi.org/10.1007/s40256-020-00406-0.
141. COVID-19 pandemic: effects and evidence-based recommendations for otolaryngology and head and
neck surgery practice. Kowalski LP, Sanabria A, Ridge JA, Ng WT, de Bree R, Rinaldo A, et al. Head & neck. 2020.
http://dx.doi.org/10.1002/hed.26164.
142. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and
lung injury: implications for COVID-19. Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et
al. Cardiovascular research. 2020. http://dx.doi.org/10.1093/cvr/cvaa097.
143. Influence of observer-dependency on left ventricular hypertrabeculation mass measurement and its
relationship with left ventricular volume and ejection fraction - comparison between manual and
semiautomatic CMR image analysis methods. Kubik M, Dabrowska-Kugacka A, Dorniak K, Kutniewska-Kubik M,
Danilowicz-Szymanowicz L, Lewicka E, et al. PLoS One. 2020;15(3):e0230134.
http://dx.doi.org/10.1371/journal.pone.0230134. eCollection 2020.
144. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Kui L, Fang YY,
Deng Y, Liu W, Wang MF, Ma JP, et al. Chinese medical journal. 2020.
145. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019
(COVID-19): The epidemic and the challenges. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. International journal of
antimicrobial agents. 2020;55(3).
146. What we know so far: COVID-19 current clinical knowledge and research. Lake MA. Clinical medicine
(London, England). 2020;20(2):124-7.
147. Clinical features of deaths in the novel coronavirus epidemic in China. Leung C. Reviews in Medical
Virology. 2020.
148. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Li B, Yang J, Zhao F,
Zhi L, Wang X, Liu L, et al. Clinical Research in Cardiology. 2020.
149. Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension.
Li G, Hu R, Zhang X. Hypertension research : official journal of the Japanese Society of Hypertension. 2020.
http://dx.doi.org/10.1038/s41440-020-0433-1.
150. The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis. Li J-W,
Han T-W, Woodward M, Anderson CS, Zhou H, Chen Y-D, et al. Progress in Cardiovascular Diseases. 2020.
151. The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia. Li K, Wu
J, Wu F, Guo D, Chen L, Fang Z, et al. Investigative radiology. 2020.
152. Atypical presentation of SARS-CoV-2 infection: A case report. Li RL, Chu SG, Luo Y, Huang ZH, Hao Y,
Fan CH. World Journal of Clinical Cases. 2020;8(7):1265-70.
153. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a
single medical center, Wuhan, China. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. International journal of
infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
http://dx.doi.org/10.1016/j.ijid.2020.03.053.
154. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Li X, Xu S, Yu M, Wang K,
Tao Y, Zhou Y, et al. The Journal of allergy and clinical immunology. 2020. http://dx.doi.org/10.1016/j.jaci.2020.04.006.
155. [The keypoints in treatment of the critical coronavirus disease 2019 patient(2)]. Li XY, Du B, Wang YS,
Kang HYJ, Wang F, Sun B, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of
tuberculosis and respiratory diseases. 2020;43(4):277-81. http://dx.doi.org/10.3760/cma.j.cn112147-20200224-00159.
156. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory
failure of COVID-19 patients. Li YC, Bai WZ, Hashikawa T. Journal of Medical Virology. 2020.
157. Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019
(COVID-19) out of Wuhan. Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Clin Infect Dis. 2020.
http://dx.doi.org/10.1093/cid/ciaa242.
158. COVID-19: A Singapore Orthopedic resident's musings in the Emergency Department. Liang ZC, Ooi
SBS. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2020.
159. The Heart in COVID19: Primary Target or Secondary Bystander? Libby P. JACC Basic to translational
science. 2020. http://dx.doi.org/10.1016/j.jacbts.2020.04.001.
160. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the
COVID-19 pandemic. Linschoten, Asselbergs FW. European heart journal. 2020.
http://dx.doi.org/10.1093/eurheartj/ehaa280.
161. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).
Lippi G, Henry BM, Sanchis-Gomar F. European journal of preventive cardiology. 2020:2047487320916823.
http://dx.doi.org/10.1177/2047487320916823.
162. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis.
Lippi G, Wong J, Henry BM. Polish archives of internal medicine. 2020. http://dx.doi.org/10.20452/pamw.15272.
163. Non-steroidal anti-inflammatory drugs and covid-19. Little P. The BMJ. 2020;368.
164. Preliminary study of the relationship between novel coronavirus pneumonia and liver function
damage: a multicenter study. Liu C, Jiang ZC, Shao CX, Zhang HG, Yue HM, Chen ZH, et al. Zhonghua gan zang bing
za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2020;28(2):148-52.
165. The Science Underlying COVID-19: Implications for the Cardiovascular System. Liu PP, Blet A, Smyth D,
Li H. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047549.
166. [CT imaging analysis of 33 cases with the 2019 novel coronavirus infection]. Liu RR, Zhu Y, Wu MY, Liu J,
Ren R, Cao QL, et al. Zhonghua yi xue za zhi. 2020;100(13):1007-11.
http://dx.doi.org/10.3760/cma.j.cn112137-20200203-00182.
167. RCVS may relax guidance due to Covid-19. Loeb J. Veterinary Record. 2020;186(10):298.
168. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms. Lovato
A, de Filippis C. Ear, nose, & throat journal. 2020:145561320920762. http://dx.doi.org/10.1177/0145561320920762.
169. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. Lupia T, Scabini S, Mornese Pinna S, Di
Perri G, De Rosa FG, Corcione S. Journal of global antimicrobial resistance. 2020;21:22-7.
http://dx.doi.org/10.1016/j.jgar.2020.02.021.
170. 2019-novel coronavirus outbreak: A new challenge. Lupia T, Scabini S, Pinna SM, Di Perri G, De Rosa FG,
Corcione S. Journal of global antimicrobial resistance. 2020.
171. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. Madjid M, Safavi-Naeini P,
Solomon SD, Vardeny O. JAMA Cardiol. 2020. http://dx.doi.org/10.1001/jamacardio.2020.1286.
172. Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with
coronavirus infection: A case report and literature review. Magdi M, Rahil A. European Journal of Case Reports in
Internal Medicine. 2019;6(7).
173. RARE CASE OF MORTALITY FROM NON-CIRRHOTIC HYPERAMMONEMIA. Maher D, Chapman K. Chest.
2019;156(4):A2125.
174. Feline infectious peritonitis as a systemic inflammatory disease: Contribution of liver and heart to the
pathogenesis. Malbon AJ, Fonfara S, Meli ML, Hahn S, Egberink H, Kipar A. Viruses. 2019;11(12).
175. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. JAMA Neurol. 2020. http://dx.doi.org/10.1001/jamaneurol.2020.1127.
176. Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory
disease and admission to the pediatric intensive care unit: A one-year study in Southeast Brazil. Matsuno AK,
Gagliardi TB, Paula FE, Luna LKS, Jesus BLS, Stein RT, et al. PLoS ONE. 2019;14(6).
177. Equine Coronavirus-Associated Colitis in Horses: A Retrospective Study. Mattei DN, Kopper JJ, Sanz MG.
Journal of Equine Veterinary Science. 2020;87.
178. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Mattiuzzi C, Lippi G. Annals of
Translational Medicine. 2020;8(3).
179. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage
Activation Syndrome-Like Disease. McGonagle D, Sharif K, O'Regan A, Bridgewood C. Autoimmunity Reviews. 2020.
180. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe
Acute Respiratory Syndrome Coronavirus Fusion Peptide. Meher G, Bhattacharjya S, Chakraborty H. The journal of
physical chemistry B. 2019;123(50):10654-62.
181. Mass gatherings medicine: public health issues arising from mass gathering religious and sporting
events. Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, et al. The Lancet. 2019;393(10185):2073-84.
182. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with
hypertension. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, et al. Emerg Microbes Infect. 2020;9(1):757-60.
http://dx.doi.org/10.1080/22221751.2020.1746200.
183. Patterns of heart Injury in COVID - 19 and relation to outcome. Mishra AK, Sahu KK, Lal A, Sargent J. J
Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25847.
184. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic
targets. Misra DP, Agarwal V, Gasparyan AY, Zimba O. Clin Rheumatol. 2020.
http://dx.doi.org/10.1007/s10067-020-05073-9.
185. The Causes of Canine Myocarditis and Myocardial Fibrosis Are Elusive by Targeted Molecular Testing:
Retrospective Analysis and Literature Review. Molesan A, Goodman L, Ford J, Lovering SJ, Kelly K. Veterinary
Pathology. 2019;56(5):761-77.
186. The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19
Era. Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, et al. European neurology. 2020:1-3.
http://dx.doi.org/10.1159/000507666.
187. COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus. Muniyappa R, Gubbi S. American journal of
physiology Endocrinology and metabolism. 2020. http://dx.doi.org/10.1152/ajpendo.00124.2020.
188. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications. Murray E,
Tomaszewski M, Guzik TJ. Cardiovascular research. 2020. http://dx.doi.org/10.1093/cvr/cvaa096.
189. Inter-study repeatability of circumferential strain and diastolic strain rate by CMR tagging, feature
tracking and tissue tracking in ST-segment elevation myocardial infarction. Nazir SA, Shetye AM, Khan JN, Singh
A, Arnold JR, Squire I, et al. The international journal of cardiovascular imaging. 2020.
http://dx.doi.org/10.1007/s10554-020-01806-8.
190. Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality.
Ogen Y. The Science of the total environment. 2020;726:138605. http://dx.doi.org/10.1016/j.scitotenv.2020.138605.
191. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to
Thailand, January 2020. Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, et al.
Eurosurveillance. 2020;25(8).
192. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?
Olds JL, Kabbani N. The FEBS journal. 2020.
193. COVID-19, diabetes mellitus and ACE2: The conundrum. Pal R, Bhansali A. Diabetes Research and Clinical
Practice. 2020;162.
194. Production of a Monoclonal Antibody Targeting the M Protein of MERS-CoV for Detection of
MERS-CoV Using a Synthetic Peptide Epitope Formulated with a CpG–DNA–Liposome Complex. Park BK, Lee SI,
Bae JY, Park MS, Lee Y, Kwon HJ. International Journal of Peptide Research and Therapeutics. 2019;25(3):819-26.
195. Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus
among hemodialysis patients: A 2-year prospective cohort study. Park HC, Lee SH, Kim J, Kim DH, Cho A, Jeon HJ,
et al. Medicine (United States). 2020;99(3).
196. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV.
Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, et al. Zhonghua xin xue guan bing za zhi. 2020;48:E004.
197. Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare? Percy E, Luc JGY,
Vervoort D, Hirji S, Ruel M, Coutinho T. The Canadian journal of cardiology. 2020.
http://dx.doi.org/10.1016/j.cjca.2020.04.006.
198. Exercising heart and head in managing coronavirus disease 2019 in wuhan. Perlis RH. JAMA Network
Open. 2020.
199. A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the
coronavirus outbreak: Take-home messages from the Italian experience. Piepoli MF, Emdin M. European Journal
of Preventive Cardiology. 2020.
200. Journey of a Thai Taxi driver and novel coronavirus. Pongpirul WA, Pongpirul K, Ratnarathon AC,
Prasithsirikul W. New England Journal of Medicine. 2020;382(11):1067-8.
201. Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. Rahimi
F, Talebi Bezmin Abadi A. Archives of medical research. 2020. http://dx.doi.org/10.1016/j.arcmed.2020.03.005.
202. Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic
events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the
context of COVID-19 pandemia. Rauch B. European journal of preventive cardiology. 2020:2047487320920754.
http://dx.doi.org/10.1177/2047487320920754.
203. Feline infectious peritonitis in a cat presented because of papular skin lesions. Redford T, Al-Dissi AN.
Canadian Veterinary Journal. 2019;60(2):183-5.
204. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Rico-Mesa JS, White A, Anderson AS.
Current cardiology reports. 2020;22(5):31. http://dx.doi.org/10.1007/s11886-020-01291-4.
205. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Ritchie AI,
Singanayagam A. Lancet. 2020;395(10230):1111. http://dx.doi.org/10.1016/S0140-6736(20)30691-7. Epub 2020 Mar
24.
206. COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm? Rizzo P, Vieceli Dalla
Sega F, Fortini F, Marracino L, Rapezzi C, Ferrari R. Basic research in cardiology. 2020;115(3):31.
http://dx.doi.org/10.1007/s00395-020-0791-5.
207. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Ronco C, Navalesi
P, Vincent JL. The Lancet Respiratory Medicine. 2020;8(3):240-1.
208. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Rossi GP,
Sanga V, Barton M. eLife. 2020;9. http://dx.doi.org/10.7554/eLife.57278.
209. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.
Rubino S, Kelvin N, Bermejo-Martin JF, Kelvin DJ. Journal of Infection in Developing Countries. 2020;14(3):265-7.
210. Angiotensin Receptor Blockers and 2019-nCoV. Saavedra JM. Pharmacological research. 2020:104832.
http://dx.doi.org/10.1016/j.phrs.2020.104832.
211. Prey in Heroes' Capes. Sabatino J. JACC Case reports. 2020. http://dx.doi.org/10.1016/j.jaccas.2020.04.002.
212. Quantification of blood flow in the fetus with cardiovascular magnetic resonance imaging using
Doppler ultrasound gating: validation against metric optimized gating. Salehi D, Sun L, Steding-Ehrenborg K,
Bidhult S, Kording F, Ruprecht C, et al. Journal of cardiovascular magnetic resonance : official journal of the Society for
Cardiovascular Magnetic Resonance. 2019;21(1):74. http://dx.doi.org/10.1186/s12968-019-0586-8.
213. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. AJR American journal of roentgenology. 2020:1-7.
214. Detection of feline coronavirus mutations in paraffin-embedded tissues in cats with feline infectious
peritonitis and controls. Sangl L, Matiasek K, Felten S, Gründl S, Bergmann M, Balzer HJ, et al. Journal of Feline
Medicine and Surgery. 2019;21(2):133-42.
215. Prevalence of selected cardiotropic pathogens in the myocardium of adult dogs with unexplained
myocardial and rhythm disorders or with congenital heart disease. Santilli RA, Grego E, Battaia S, Gianella P, Tursi
M, Di Girolamo N, et al. Journal of the American Veterinary Medical Association. 2019;255(10):1150-60.
216. Hypertension and COVID-19. Schiffrin EL, Flack J, Ito S, Muntner P, Webb C. American journal of
hypertension. 2020. http://dx.doi.org/10.1093/ajh/hpaa057.
217. Diagnostic study on diarrhoea in dogs in Ludhiana, Punjab. Sen C, Sharma AK, Singh R, Chandra M,
Sharma S. Veterinary Practitioner. 2019;20(1):59-63.
218. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the
Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement. Shah PB, Welt FGP,
Mahmud E, Phillips A, Kleiman NS, Young MN, et al. Catheterization and cardiovascular interventions : official journal
of the Society for Cardiac Angiography & Interventions. 2020. http://dx.doi.org/10.1002/ccd.28910.
219. COVID-19 And Older Adults: What We Know. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D,
Ramgobin D, Patel R, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16472.
220. Cerebellar Scholars' Challenging Time in COVID-19 Pandemia. Shaikh AG, Mitoma H, Manto M.
Cerebellum. 2020. http://dx.doi.org/10.1007/s12311-020-01131-9.
221. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Shao
F, Xu S, Ma X, Xu Z, Lyu J, Ng M, et al. Resuscitation. 2020. http://dx.doi.org/10.1016/j.resuscitation.2020.04.005.
222. Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19
Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care
(SNACC)_Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional
Surgery (SNIS), Neurocritical Care Society (NCS), and European Society of Minimally Invasive Neurological
Therapy (ESMINT). Sharma D, Rasmussen M, Han R, Whalin M, Davis M, Kofke WA, et al. Journal of neurosurgical
anesthesiology. 2020. http://dx.doi.org/10.1097/ANA.0000000000000688.
223. 2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs. Shi HZ, Ma P, Gao
FY, Chen GL, Yu YH, Wang XD, et al. Zhonghua xin xue guan bing za zhi. 2020;48:E010.
224. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. JAMA Cardiol. 2020. http://dx.doi.org/10.1001/jamacardio.2020.0950.
225. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases
outside Wuhan. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Critical Care. 2020;24(1).
226. Countermeasures and treatment for aortic acute syndrome with 2019 coronavirus disease. Si Y, Sun XF,
Zhong M, Yue JN, Fu WG. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2020;58(3):178-82.
227. Countermeasures and treatment for aortic acute syndrome with novel coronavirus pneumonia. Si Y,
Sun XF, Zhong M, Yue JN, Fu WG. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2020;58:E002.
228. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. Silverstein
WK, Stroud L, Cleghorn GE, Leis JA. The Lancet. 2020;395(10225):734.
229. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
requiring invasive mechanical ventilation. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et
al. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22831.
230. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin
angiotensin system blockers. Singh AK, Gupta R, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and
Reviews. 2020;14(4):283-7.
231. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin
Receptor Blockers Have a Biphasic Effect? Sommerstein R, Kochen MM, Messerli FH, Grani C. Journal of the
American Heart Association. 2020;9(7):e016509. http://dx.doi.org/10.1161/JAHA.120.016509. Epub 2020 Apr 1.
232. Respiratory Pathogens in Infants Diagnosed with Acute Lower Respiratory Tract Infection in a Tertiary
Care Hospital of Western India Using Multiplex Real Time PCR. Sonawane AA, Shastri J, Bavdekar SB. Indian
Journal of Pediatrics. 2019;86(5):433-8.
233. COVID-19, ACE2 and the Cardiovascular Consequences. South AM, Diz D, Chappell MC. American journal
of physiology Heart and circulatory physiology. 2020. http://dx.doi.org/10.1152/ajpheart.00217.2020.
234. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Sparks MA, South A,
Welling P, Luther JM, Cohen J, Byrd JB, et al. Clinical journal of the American Society of Nephrology : CJASN. 2020.
http://dx.doi.org/10.2215/CJN.03530320.
235. Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple. Spezzani
V, Piunno A, Iselin HU. Swiss medical weekly. 2020;150:w20246. http://dx.doi.org/10.4414/smw.2020.20246.
eCollection 2020 Apr 6.
236. Cardiovascular Risk Factors and Complications in Patients Infected with COVID-19: A Systematic
Review. Sreenivasan J, Khan MS, Anker SD, Kaul R, Khan SU, Metra M, et al. Available at SSRN 3569855. 2020.
237. Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience
From Milan, Italy. Stefanini GG, Azzolini E, Condorelli G. Circulation. 2020.
238. COVID-19: Risk Groups, Mechanistic Insights, and Challenges. Stein R. Int J Clin Pract. 2020:e13512.
http://dx.doi.org/10.1111/ijcp.13512.
239. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future
Management. Stoian AP, Banerjee Y, Rizvi AA, Rizzo M. Metabolic syndrome and related disorders. 2020.
http://dx.doi.org/10.1089/met.2020.0037.
240. [Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].
Sun C, Zhang XB, Dai Y, Xu XZ, Zhao J. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese
journal of tuberculosis and respiratory diseases. 2020;43:E042.
http://dx.doi.org/10.3760/cma.j.cn112147-20200224-00168.
241. High-frequency oscillatory ventilation in treating severe pediatric ards caused by pneumocystis
jiroveci pneumonia and multiple viral infections. Sung TH, Lo YC, Tang YH, Chen WY, Tsao PC, Lee YS, et al.
Pediatric Pulmonology. 2019;54:S133-S4.
242. Considerations for Cardiac Catheterization Laboratory Procedures During the COVID-19 Pandemic
Perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship
(SCAI ELM) Members and Graduates. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, Dehghani P, et
al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &
Interventions. 2020. http://dx.doi.org/10.1002/ccd.28887.
243. Antiviral activity of itraconazole against type i feline coronavirus infection. Takano T, Akiyama M, Doki
T, Hohdatsu T. Veterinary Research. 2019;50(1).
244. Endocytic pathway of feline coronavirus for cell entry: Differences in serotype-dependent viral entry
pathway. Takano T, Wakayama Y, Doki T. Pathogens. 2019;8(4).
245. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting
enzyme inhibitors in relation to COVID-19 (corona virus disease 2019). Talreja H, Tan J, Dawes M, Supershad S,
Rabindranath K, Fisher J, et al. The New Zealand medical journal. 2020;133(1512):85-7.
246. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial
Infarction Care in Hong Kong, China. Tam CCF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Circulation
Cardiovascular quality and outcomes. 2020:CIRCOUTCOMES120006631.
247. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart
disease. Tan W, Aboulhosn J. International Journal of Cardiology. 2020.
248. Italian Society of Interventional Cardiology (GISE) Position Paper for Cath lab-specific Preparedness
Recommendations for Healthcare providers in case of suspected, probable or confirmed cases of COVID-19.
Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino FF, Rigattieri S, et al. Catheterization and cardiovascular
interventions : official journal of the Society for Cardiac Angiography & Interventions. 2020.
http://dx.doi.org/10.1002/ccd.28888.
249. The gendered dimensions of COVID-19. The L. The Lancet. 2020;395(10231):1168.
250. COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond? Thomson G.
International journal of clinical practice. 2020:e13503.
251. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core
biopsies. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Modern pathology : an official journal of the United States
and Canadian Academy of Pathology, Inc. 2020. http://dx.doi.org/10.1038/s41379-020-0536-x.
252. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19).
Tolksdorf K, Buda S, Schuler E, Wieler LH, Haas W. Eurosurveillance. 2020;25(11).
253. ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory
syndrome-coronavirus and COVID-19. Touyz RM, Li H, Delles C. Clinical science (London, England : 1979).
2020;134(7):747-50. http://dx.doi.org/10.1042/CS20200363.
254. Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015. van Kerkhove
MD, Aswad S, Assiri A, Perera RAPM, Peiris M, El Bushra HE, et al. Emerging Infectious Diseases. 2019;25(10):1802-9.
255. [Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units].
Vega-Vega O, Arvizu-Hernandez M, Dominguez-Cherit JG, Sierra-Madero J, Correa-Rotter R. Salud publica de Mexico.
2020. http://dx.doi.org/10.21149/11330.
256. Rapid Scholarly Dissemination and Cardiovascular Community Engagement to Combat the Infodemic
of the COVID-19 Pandemic. Vervoort D, Ma X, Luc JGY, Zieroth S. The Canadian journal of cardiology. 2020.
http://dx.doi.org/10.1016/j.cjca.2020.03.042.
257. Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk.
Vuorio A, Watts GF, Kovanen PT. Journal of internal medicine. 2020. http://dx.doi.org/10.1111/joim.13070.
258. Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing. Wan S, Xiang Y, Fang W,
Zheng Y, Li B, Hu Y, et al. Journal of medical virology. 2020.
259. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Wang B,
Li R, Lu Z, Huang Y. Aging (Albany NY). 2020;12. http://dx.doi.org/10.18632/aging.103000.
260. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia
in Wuhan, China. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. JAMA - Journal of the American Medical
Association. 2020;323(11):1061-9.
261. Potential neurological symptoms of COVID-19. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW.
Therapeutic Advances in Neurological Disorders. 2020;13.
262. Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress
Syndrome (ARDS): A Case Series. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Journal
of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14828.
263. Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply. Wang J, Shi Y. The
Lancet Child and Adolescent Health. 2020;4(4):e9.
264. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week
follow-up. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.019.
265. Structural and biochemical characterization of SADS-CoV papain-like protease 2. Wang L, Hu W, Fan C.
Protein Science. 2020.
266. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a
Fangcang Hospital. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical microbiology and infection : the
official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.
http://dx.doi.org/10.1016/j.cmi.2020.03.032.
267. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for
SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. Wang Z, Xu X. Cells. 2020;9(4).
http://dx.doi.org/10.3390/cells9040920.
268. PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated endocytosis and traffics via the
endo-/lysosome pathway. Wei X, She G, Wu T, Xue C, Cao Y. Veterinary Research. 2020;51(1).
269. Myocardial injury in patients with COVID-19 pneumonia. Wei ZY, Qian HY. Zhonghua xin xue guan bing
za zhi. 2020;48:E006.
270. Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19
Pandemic: Guidance from Canadian Association of Interventional Cardiology. Wood DA, Sathananthan J, Gin K,
Mansour S, Ly HQ, Quraishi AU, et al. The Canadian journal of cardiology. 2020.
http://dx.doi.org/10.1016/j.cjca.2020.03.027.
271. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with
Coronavirus Disease 2019 Pneumonia in Wuhan, China. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. JAMA
Internal Medicine. 2020.
272. Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human
nutrition and health. Wu G. Amino Acids. 2020;52(3):329-60.
273. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients
with novel coronavirus disease (COVID-19). Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, et al. Journal of internal
medicine. 2020. http://dx.doi.org/10.1111/joim.13063.
274. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei
Province, China. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. JAMA ophthalmology. 2020.
275. Coronaviruses and the cardiovascular system: acute and long-term implications. Xiong TY, Redwood S,
Prendergast B, Chen M. European heart journal. 2020.
276. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Xu K, Chen Y, Yuan J,
Yi P, Ding C, Wu W, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa351.
277. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Xu X, Yu C, Qu J,
Zhang L, Jiang S, Huang D, et al. European Journal of Nuclear Medicine and Molecular Imaging. 2020.
278. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19
and Cardiovascular Diseases. Yang C, Jin Z. JAMA Cardiol. 2020. http://dx.doi.org/10.1001/jamacardio.2020.0934.
279. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic
review and meta-analysis. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. International journal of infectious
diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
280. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. The Lancet
Respiratory Medicine. 2020.
281. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an
ongoing pandemic. Yeo TJ, Wang YTL, Low TT. European Journal of Preventive Cardiology. 2020.
282. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing
the COVID-19 pandemic emergency. Zangrillo A, Beretta L, Silvani P, Colombo S, Scandroglio AM, Dell'Acqua A, et
al. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2020.
283. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial
People’s Hospital. Zeng J, Huang J, Pan L. Intensive Care Medicine. 2020.
284. Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective
observational study. Zeng Z, Sha T, Zhang Y, Wu F, Hu H, Li H, et al. medRxiv. 2020:2020.04.06.20054825.
285. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ, Dong X,
Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Allergy: European Journal of Allergy and Clinical Immunology. 2020.
286. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II
Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Zhang P,
Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Circ Res. 2020. http://dx.doi.org/10.1161/CIRCRESAHA.120.317134.
287. Imaging changes in severe COVID-19 pneumonia. Zhang W. Intensive Care Med. 2020;46(4):583-5.
http://dx.doi.org/10.1007/s00134-020-05976-w. Epub 2020 Mar 3.
288. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.
Zhang X, Song K, Tong F, Fei M, Guo H, Lu Z, et al. Blood Adv. 2020;4(7):1307-10.
http://dx.doi.org/10.1182/bloodadvances.2020001907.
289. Cholesterol 25-hydroxylase negatively regulates porcine intestinal coronavirus replication by the
production of 25-hydroxycholesterol. Zhang Y, Song Z, Wang M, Lan M, Zhang K, Jiang P, et al. Veterinary
Microbiology. 2019;231:129-38.
290. Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19)
Outbreak. Zhao J, Rudd A, Liu R. Stroke. 2020:Strokeaha120029701.
http://dx.doi.org/10.1161/STROKEAHA.120.029701.
291. Anesthetic Management of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection
During Emergency Procedures. Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, et al. Journal of Cardiothoracic and
Vascular Anesthesia. 2020.
292. Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures. Zhao S,
Ling K, Yan H, Zhong L, Peng X, Yao S, et al. J Cardiothorac Vasc Anesth. 2020;34(5):1125-31.
http://dx.doi.org/10.1053/j.jvca.2020.02.039. Epub 2020 Feb 28.
293. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Zheng F,
Tang W, Li H, Huang YX, Xie YL, Zhou ZG. European review for medical and pharmacological sciences.
2020;24(6):3404-10. http://dx.doi.org/10.26355/eurrev_202003_20711.
294. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19
in Chengdu. Zheng Y, Xu H, Yang M, Zeng Y, Chen H, Liu R, et al. Journal of clinical virology : the official publication
of the Pan American Society for Clinical Virology. 2020;127:104366. http://dx.doi.org/10.1016/j.jcv.2020.104366.
295. COVID-19 and the cardiovascular system. Zheng YY, Ma YT, Zhang JY, Xie X. Nature Reviews Cardiology.
2020.
296. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in
anaesthetists: retrospective, single-centre, observational cohort study. Zhong Q, Liu YY, Luo Q, Zou YF, Jiang HX,
Li H, et al. British Journal of Anaesthesia. 2020.
297. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza
respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network. Zhou F,
Wang Y, Liu Y, Liu X, Gu L, Zhang X, et al. European Respiratory Journal. 2019;54(2).
298. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. The Lancet. 2020.
299. [Attention should be paid to the exposure risk of patients with chronic wounds on the way to hospital
during corona virus disease 2019 epidemic prevention and control]. Zhou JQ, Dong W, Xu HL, Cai YM, Sheng DH,
Wu FY, et al. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 2020;36:E003.
http://dx.doi.org/10.3760/cma.j.cn501120-20200218-00065.
300. Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical
characteristics. Zhu ZW, Tang JJ, Chai XP, Fang ZF, Liu QM, Hu XQ, et al. Zhonghua xin xue guan bing za zhi.
2020;48:E007.
301. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of
different human organs vulnerable to 2019-nCoV infection. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Frontiers of
medicine. 2020.
302. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and
meta-analysis. Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. J Infect. 2020.
http://dx.doi.org/10.1016/j.jinf.2020.03.059.
